ARTICLE | Clinical News
Zovant drotrecogin alfa: Phase III
February 12, 2001 8:00 AM UTC
LLY published in The New England Journal of Medicine results from a U.S. Phase III trial in 1,690 patients with sepsis in which patients who received drotrecogin alfa infusion at 24 ug/kg/hr for 96 ho...